PRESS RELEASE published on 11/28/2025 at 08:30, 5 months 2 days ago Results of the Votes of the Combined Shareholders’ General Meeting of November 27, 2025 Inventiva announces results of Combined Shareholders’ General Meeting of November 27, 2025. Approval of resolutions, except for the 5th resolution. Details on compensation policy and voting results disclosed Voting Results Shareholders' Meeting Clinical-Stage Biopharmaceutical Inventiva Compensation Policy
BRIEF published on 11/21/2025 at 22:05, 5 months 9 days ago Inventiva's 2025 Q3 Financial Update Financial Results Revenue Growth Biopharmaceutical Inventiva Q3 2025
PRESS RELEASE published on 11/21/2025 at 22:00, 5 months 9 days ago Inventiva reports 2025 Third Quarter Financial Information¹ Inventiva reports financial information for Q3 2025, showcasing cash position, revenues, and runway until Q1 2027. Details on operating activities, investing activities, and financing activities provided Financial Information Revenues Inventiva Cash Runway Q3 2025
BRIEF published on 11/21/2025 at 11:26, 5 months 9 days ago Sofinnova Partners crosses threshold in INVENTIVA Threshold Crossing Shares And Voting Rights Inventiva Sofinnova Partners Subscription Vouchers
BRIEF published on 11/21/2025 at 11:25, 5 months 9 days ago Crossing of thresholds by Samsara BioCapital at INVENTIVA Voting Rights Capital Increase Threshold Crossing Inventiva Samsara BioCapital
PRESS RELEASE published on 11/13/2025 at 15:21, 5 months 17 days ago Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares
BRIEF published on 11/13/2025 at 08:45, 5 months 17 days ago Inventiva Announces Temporary Trading Halt on Euronext Paris Euronext Paris Nasdaq Trading Halt Inventiva ADS Offering
PRESS RELEASE published on 11/13/2025 at 08:40, 5 months 17 days ago Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris Inventiva temporarily halts trading of ordinary shares on Euronext Paris for public offering preparation, with expected resumption by end of day. Company focuses on MASH treatment research Euronext Paris Trading Halt Public Offering Inventiva MASH Treatment
BRIEF published on 10/14/2025 at 22:05, 6 months 17 days ago Inventiva Launches New ATM Program to Raise $100 Million Biopharmaceutical SEC Filing Inventiva Lanifibranor ATM Program
PRESS RELEASE published on 10/14/2025 at 22:00, 6 months 17 days ago Inventiva Announces the Implementation of a New ATM Program Inventiva implements new ATM program, files Registration Statement with the SEC for up to $100 million aggregate gross sales proceeds. Proceeds to fund research and development, working capital, and corporate purposes Biopharmaceutical SEC Registration Statement Inventiva ATM Program
Published on 05/01/2026 at 04:00, 1 hour 8 minutes ago Jericho Energy Ventures Announces Short Delay in Filing of 2025 Annual Financial Statements
Published on 05/01/2026 at 03:25, 1 hour 43 minutes ago McEwen Inc. and Golden Lake Exploration Inc. Announce Closing of Arrangement
Published on 05/01/2026 at 02:55, 2 hours 13 minutes ago GLG Life Tech Corporation Reports 2025 Annual & Fourth Quarter Financial Results
Published on 05/01/2026 at 01:00, 4 hours 8 minutes ago PPX Mining Announces Grant of Stock Options, Restricted Share Units and Deferred Share Units
Published on 05/01/2026 at 00:45, 4 hours 23 minutes ago Inventus Announces Closing of $2.5 Million Non-Brokered Flow-Through Financing
Published on 04/30/2026 at 23:39, 5 hours 29 minutes ago Anemoi International Ltd: Final Results For Year Ended 31 December 2025
Published on 04/30/2026 at 22:35, 6 hours 32 minutes ago Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharma
Published on 04/30/2026 at 22:04, 7 hours 3 minutes ago Interim individual financial statements for the period ending on March 31, 2026 of Sirma Group Holding JSC
Published on 04/30/2026 at 19:00, 10 hours 7 minutes ago DOUGLAS Group grows sales in Q2 and updates full-year guidance on adjusted EBITDA
Published on 04/30/2026 at 19:00, 10 hours 8 minutes ago BioVersys announces approval of all Board Proposals at Annual General Meeting of Shareholders
Published on 04/30/2026 at 20:00, 9 hours 7 minutes ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 9 hours 52 minutes ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 10 hours 8 minutes ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 10 hours 58 minutes ago Minutes of the Combined General Meeting held on April 30, 2026
